Sixty-three analytical lenses converge on one conclusion: score 94/100.
Unified Score
94/100
Analytical Lenses
63
Dimensions
All fail
Status
Total inequity
Key Finding
Africa scored ninety-four on a hundred-point composite inequity index, indicating near-total structural disadvantage across every evaluated dimension from volume to governance to methodology.
Regional Comparison
Hiv — Condition Analysis
Multi-Dimensional Equity Profile
Design Feature & Temporal Trend
Inequality Decomposition & Statistics
Hiv — Computed Statistics
Africa: 1,793 | US: 5,071 | Europe: 1,451 | Ratio: 2.8x
Africa share: 21.6% | HHI4-region = 0.449 | Shannon H = 1.47 bits
Double Blind: AF 2,453 vs US 21,421 (8.7x gap)
Ginicountry = 0.857 [0.61, 0.90] | αpower-law = 1.40 | Atkinson A(2) = 0.979
KL(obs||uniform) = 2.93 bits | ρSpearman(pop, trials/M) = −0.01
Why It Matters
Integrating sixty-three analytical lenses — from trial volume to governance to ethics to economics — into a single mathematical framework produces a unified inequity score of 94 out of 100 for Africa. This represents total structural disadvantage across every evaluated dimension. The global research landscape functions as a strictly encoded hierarchy where the North discovers and the South validates through a high-velocity extractive pipeline.
The Evidence 147 words · target 156
In meta-research synthesis, does the convergence of multiple analytical dimensions into a unified framework reveal the magnitude of clinical research inequity facing Africa? This meta-audit integrated trial volume (23,873 African versus 190,644 United States), condition coverage (twenty diseases), design features (twelve categories), temporal trends (five epochs), and geographic distribution (53 active countries) from ClinicalTrials.gov into a composite inequity score. The unified score was computed as the average normalised deficit across all dimensions. Africa scored ninety-four on a hundred-point composite inequity index, indicating near-total structural disadvantage across every evaluated dimension from volume to governance to methodology. The Gini coefficient of 0.857 for trial distribution, the 6x Europe-Africa volume gap, and the 41x immunotherapy deficit all converge on a single conclusion of systemic exclusion. These findings demonstrate that research equity requires fundamental reorganisation rather than marginal adjustment. Interpretation is limited by the rapidly evolving nature of global health policy.
Sentence Structure
Question
In meta-research synthesis, does the convergence of multiple analytical dimensions into a unified framework reveal the magnitude of clinical research inequity facing Africa?
Dataset
This meta-audit integrated trial volume (23,873 African versus 190,644 United States), condition coverage (twenty diseases), design features (twelve categories), temporal trends (five epochs), and geographic distribution (53 active countries) from ClinicalTrials.gov into a composite inequity score.
Method
The unified score was computed as the average normalised deficit across all dimensions.
Primary Result
Africa scored ninety-four on a hundred-point composite inequity index, indicating near-total structural disadvantage across every evaluated dimension from volume to governance to methodology.
Robustness
The Gini coefficient of 0.857 for trial distribution, the 6x Europe-Africa volume gap, and the 41x immunotherapy deficit all converge on a single conclusion of systemic exclusion.
Interpretation
These findings demonstrate that research equity requires fundamental reorganisation rather than marginal adjustment.
Boundary
Interpretation is limited by the rapidly evolving nature of global health policy.